Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Liabilities and Shareholders Equity: 2022-2025

Historic Liabilities and Shareholders Equity for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $11.5 million.

  • bioAffinity Technologies' Liabilities and Shareholders Equity rose 76.23% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year decrease of 3.80%. This contributed to the annual value of $6.5 million for FY2024, which is 20.77% down from last year.
  • bioAffinity Technologies' Liabilities and Shareholders Equity amounted to $11.5 million in Q3 2025, which was up 143.03% from $4.8 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Liabilities and Shareholders Equity high stood at $14.1 million for Q3 2022, and its period low was $4.8 million during Q2 2025.
  • For the 3-year period, bioAffinity Technologies' Liabilities and Shareholders Equity averaged around $7.9 million, with its median value being $8.0 million (2024).
  • Per our database at Business Quant, bioAffinity Technologies' Liabilities and Shareholders Equity slumped by 35.70% in 2024 and then skyrocketed by 76.23% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Liabilities and Shareholders Equity stood at $12.2 million in 2022, then tumbled by 32.51% to $8.2 million in 2023, then declined by 20.77% to $6.5 million in 2024, then spiked by 76.23% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $4.8 million for Q2 2025, and $5.5 million during Q1 2025.